Conservative treatment of postsurgical lymphatic leaks with somatostatin-14.
Successful management of lymphatic leaks by continuous IV administration of somatostatin was first reported by Ulibarri and coworkers in Spain,(1) and more recently by authors from Italy(2) and Switzerland.(3) The present article reports the clinical history of two patients in whom postsurgical lymphatic leak was successfully treated after the administration of either somatostatin-14 alone (case 1) or combined somatostatin-14 and total parenteral nutrition (TPN; case 2). Although further pathophysiologic studies are needed for the elucidation of its mechanisms of action, somatostatin-14 seems to be an intriguing therapy against postsurgical lymphatic leaks that may make potentially risky transthoracic reoperation unnecessary.
Collard
J M
JM
Departments of Surgery, St-Luc Academic Hospital, Brussels, Belgium. Collard@chir.ucl.ac.be
Laterre
P F
PF
Boemer
F
F
Reynaert
M
M
Ponlot
R
R
D003131:Combined Modality Therapy; D005402:Fistula / Q000188:drug therapy*; D006801:Humans; D007262:Infusions, Intravenous; D008196:Lymph; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000188:drug therapy*; D012008:Recurrence; D012086:Reoperation; D013004:Somatostatin / Q000008:administration & dosage*; D013525:Surgical Instruments; D013897:Thoracic Duct / Q000293:injuries* / Q000601:surgery; D013906:Thoracoscopy
D013004:Somatostatin